North America Capillary Blood Collection and Sampling Devices Market, By Product (Blood Sampling Devices, Capillary Blood Collection Devices, Rapid Test Cassette, Remote Capillary Blood Collection Device, and Wearable Capillary Blood Collection Device), Modality (Manual Sampling and Automated/Autoinjection Sampling), Mode of Administration (Puncture and Incision), Application (Cardiovascular Disease, Infection and Infectious Disease, Respiratory Diseases, Cancers, Rheumatoid Arthritis, and Others), Platform (Enzyme Immunoassay Platform (ELISA Platform), PCR Platform, Lateral Flow Immunoassay Platform, ELTABA Platform, and Others), Procedure (Conventional and Point of Care Testing), Age Group (Geriatrics, Infant, Pediatric, and Adult), Test Type (Whole Blood Test, Dried Blood Spot Tests, Plasma/Serum Protein Tests, Liver Panel/Liver Profile/Liver Function Tests, Comprehensive Metabolic Panel (CMP) Tests, and Others), Technology (Volumetric Absorptive Microsampling, Capillary Electrophoresis-Based Chemical Analysis, and Others), Material (Plastic, Glass, Stainless Steel, and Ceramic), End User (Laboratories and Home Care Setting), Distribution Channel (Direct Tender, Retail Sales, and Others) – Industry Trends and Forecast to 2031.
North America Capillary Blood Collection and Sampling Devices Market Analysis and Size
The capillary blood collection and sampling devices market is experiencing exponential growth driven by advancements in technology. The latest methods offer non-invasive, efficient, and precise sampling, revolutionizing healthcare practices. With increased demand for point-of-care diagnostics and remote patient monitoring, these innovations are reshaping the landscape, catering to diverse medical needs while enhancing patient comfort and convenience.
The North America capillary blood collection and sampling devices market size was valued at USD 1.17 billion in 2023 and is projected to reach USD 1.81 billion by 2031, with a CAGR of 5.6% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Blood Sampling Devices, Capillary Blood Collection Devices, Rapid Test Cassette, Remote Capillary Blood Collection Device, and Wearable Capillary Blood Collection Device), Modality (Manual Sampling and Automated/Autoinjection Sampling), Mode of Administration (Puncture and Incision), Application (Cardiovascular Disease, Infection and Infectious Disease, Respiratory Diseases, Cancers, Rheumatoid Arthritis, and Others), Platform (Enzyme Immunoassay Platform (ELISA Platform), PCR Platform, Lateral Flow Immunoassay Platform, ELTABA Platform, and Others), Procedure (Conventional and Point of Care Testing), Age Group (Geriatrics, Infant, Pediatric, and Adult), Test Type (Whole Blood Test, Dried Blood Spot Tests, Plasma/Serum Protein Tests, Liver Panel/Liver Profile/Liver Function Tests, Comprehensive Metabolic Panel (CMP) Tests, and Others), Technology (Volumetric Absorptive Microsampling, Capillary Electrophoresis-Based Chemical Analysis, and Others), Material (Plastic, Glass, Stainless Steel, and Ceramic), End User (Laboratories and Home Care Setting), Distribution Channel (Direct Tender, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico
|
|
Market Players Covered
|
BD (U.S.), TERUMO BCT, INC. (U.S.), Fresenius Kabi AG (Germany), Grifols, S.A. (Spain), Nipro Europe Group Companies (U.S.), Greiner Bio-One International GmbH (Austria), Quest Diagnostics Incorporated (U.S.), Mitra Industries Private Limited (India), SARSTEDT AG & Co. KG (Germany), CML Biotech (India), Macopharma (France), Neomedic Limited (U.S.), Haemonetics Corporation (U.S.), ICU Medical, Inc. (U.S.), SB-KAWASUMI LABORATORIES, INC. (Japan), and Retractable Technologies, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Capillary blood collection involves obtaining blood from capillaries close to the skin's surface, typically from a fingertip. Sampling devices, such as lancets, create a small puncture for blood collection. Microcollection tubes or capillary tubes are then used to collect the blood sample. This method is commonly employed for point-of-care testing, such as glucose monitoring or hematocrit determination, due to its simplicity and accessibility.
North America Capillary Blood Collection and Sampling Devices Market Dynamics
Drivers
- Increase in Demand for Safe Blood Collection Technologies
The increasing demand for safe blood collection technologies is being driven by concerns over the risks associated with traditional venipuncture methods. Capillary blood sampling offers advantages such as minimal pain and lower risk of complications. This has led to a surge in demand for efficient capillary collection devices. For instance, innovations such as lancets with retractable needles and pre-loaded safety features address safety concerns and enhance usability, driving market growth.
- Expansion of Point-of-Care Testing
The expansion of point-of-care testing drives demand for capillary blood collection devices, enabling rapid diagnosis and treatment decisions in diverse healthcare settings. For instance, in emergency departments, capillary blood collection devices facilitate swift blood sampling for immediate analysis, aiding in timely interventions. This demand surge underscores the crucial role of capillary blood collection devices in enhancing healthcare efficiency and patient outcomes within decentralized care environments.
Opportunities
- Rise in Home Healthcare
The surge in home healthcare preferences is fueling demand for capillary blood collection devices, enabling convenient self-monitoring of health conditions. For instance, the increasing prevalence of diabetes prompts patients to regularly monitor blood glucose levels at home using such devices. This trend not only enhances patient comfort but also reduces healthcare costs and hospital visits, thereby driving market growth for capillary blood collection and sampling devices.
- Increasing Awareness and Screening Programs
Growing awareness of preventive healthcare and early disease detection programs is fueling demand for capillary blood collection devices, facilitating convenient sample collection. For instance, initiatives promoting regular blood glucose monitoring among at-risk populations for diabetes, such as elderly individuals or those with a family history of the disease, are driving the market. These efforts prioritize early detection, encouraging the use of capillary blood collection devices for easy and frequent blood testing.
Restraints/Challenges
- Limited Sample Volume
Limited sample volume in capillary blood collection hinders the market by restricting its utility for tests requiring larger sample sizes, potentially impacting diagnostic accuracy and reliability. This limitation poses challenges for healthcare providers and may lead to reliance on alternative sampling methods, limiting market growth and adoption.
- Variability in Results
Variability in capillary blood collection results due to factors such as skin thickness, puncture depth, and refill time poses a significant challenge, undermining the reliability of test outcomes. This inconsistency impedes market growth by eroding trust in the accuracy of capillary sampling methods, discouraging widespread adoption in clinical settings.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2021, Medtronic initiated its trial to assess the safety of adaptive deep brain stimulation (aDBS) for Parkinson's disease patients. This innovative approach aims to enhance treatment outcomes by adjusting stimulation based on individual needs, potentially improving symptom management and quality of life
- In 2020, B.D. and BioMedomics collaborated to develop a groundbreaking 15-minute at-home rapid test for COVID-19 exposure. This novel testing device, offering convenience and rapid results, signifies a significant advancement in pandemic control efforts. Its introduction promises not only improved accessibility to testing but also potential revenue growth for both companies
North America Capillary Blood Collection and Sampling Devices Market Scope
The market is segmented on the basis of product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Blood Sampling Devices
- Capillary Blood Collection Devices
- Rapid Test Cassette
- Remote Capillary Blood Collection Device
- Wearable Capillary Blood Collection Device
Mode of Administration
- Puncture
- Incision
Modality
- Manual Sampling
- Automated/Autoinjection Sampling
- Mode of Administration
- Puncture
- Incision
Application
- Cardiovascular Disease
- Infection and Infectious Disease
- Respiratory Diseases
- Cancers
- Rheumatoid Arthritis
- Others
Platform
- Enzyme Immunoassay Platform (Elisa Platform)
- PCR Platform
- Lateral Flow Immunoassay Platform
- ELTABA Platform
- Others
Procedure
- Conventional
- Point of Care Testing
Age Group
- Geriatrics
- Infant
- Pediatric
- Adult
Test Type
- Whole Blood Test
- Dried Blood Spot Tests
- Plasma/Serum Protein Tests
- Liver Panel/Liver Profile/Liver Function Tests
- Comprehensive Metabolic Panel (CMP) Tests
- Others
Technology
- Volumetric Absorptive Microsampling
- Capillary Electrophoresis-Based Chemical Analysis
- Others
Material
- Plastic
- Glass
- Stainless Steel
- Ceramic
End User
- Laboratories
- Home Care Setting
Distribution Channel
- Direct Tender
- Retail Sales
- Others
North America Capillary Blood Collection and Sampling Devices Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, product, modality, mode of administration, application, platform, procedure, age group, test type, technology, material, end user, and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada and Mexico.
The U.S. is expected to dominate the capillary blood collection and sampling devices market, leveraging advanced technologies and a heightened focus on clinical research. With a robust healthcare infrastructure, the nation drives innovation, ensuring superior quality and efficacy in blood collection methodologies for enhanced patient care and diagnostic accuracy.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and North America Capillary Blood Collection and Sampling Devices Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- BD (U.S.)
- TERUMO BCT, INC. (U.S.)
- Fresenius Kabi AG (Germany)
- Grifols, S.A. (Spain)
- Nipro Europe Group Companies (U.S.)
- Greiner Bio-One International GmbH (Austria)
- Quest Diagnostics Incorporated (U.S.)
- Mitra Industries Private Limited (India)
- SARSTEDT AG & Co. KG (Germany)
- CML Biotech (India)
- Macopharma (France)
- Neomedic Limited (U.S.)
- Haemonetics Corporation (U.S.)
- ICU Medical, Inc. (U.S.)
- SB-KAWASUMI LABORATORIES, INC. (Japan)
- Retractable Technologies, Inc. (U.S.)
SKU-